Results 61 to 70 of about 32,595 (294)
Marijuana Legislation: Identifying the Impact on the Oral Healthcare Provider [PDF]
, 2020 Objectives/Aims: Since the mid-2000s, the United States has seen a surge in legislation involving the legalization of marijuana, both recreationally and medicinally.
Geiser, Abby L, Reid-Burrell, Jessica
core +1 more source
The therapeutic aspects of the endocannabinoid system (ECS) for cancer and their development: from nature to laboratory [PDF]
, 2016 The endocannabinoid system (ECS) is a group of neuromodulatory lipids and their receptors, which are widely distributed in mammalian tissues. ECS regulates various cardiovascular, nervous, and immune system functions inside cells.
Botta, Bruno +5 more
core +1 more source
Exploring new avenues: Psychedelic‐assisted therapy for young people
British Journal of Clinical Pharmacology, EarlyView.Rates of mental illness in young people are increasing, whereas the development of novel mental health treatments has not significantly progressed. Psychedelic‐assisted therapy, using substances such as psilocybin and 3,4‐methylenedioxymethamphetamine (MDMA), has shown potential in the treatment of mental illnesses in the adult population, including ...
Ioanna Artemis Vamvakopoulou +3 more
wiley +1 more source
Journal of Cannabis ResearchBackground Proposition 64, the Adult Use of Marijuana Act of 2016, reshaped cannabis use in California. This study explores the use patterns of people who use cannabis for medicinal-only and combined medicinal and recreational use after implementation of
Daniel Ageze +8 more
doaj +1 more source
A Provider\u27s Guide to Medical Cannabis: THC and CBD. Putting the Evidence to Work for Improved Patient Care [PDF]
, 2019 Please use abstract uploaded with previous powerpointhttps://scholarworks.uvm.edu/fmclerk/1504/thumbnail ...
Smith, Danielle
core +1 more source
Clinical trials of medicinal cannabis for appetite-related symptoms from advanced cancer: a survey of preferences, attitudes and beliefs among patients willing to consider participation [PDF]
, 2016 © 2016 Royal Australasian College of Physicians Background: Australian clinical trials are planned to evaluate medicinal cannabis in a range of clinical contexts. Aims: To explore the preferences, attitudes and beliefs of patients eligible and willing to
Agar, M +14 more
core +2 more sources
Clinical Pharmacology &Therapeutics, EarlyView.Despite known risks, opioids are widely used for chronic non‐cancer pain (CNCP). Clinical guidelines now recommend deprescribing, but factors predicting success are poorly understood. This systematic review aimed to identify clinician and patient factors associated with attaining successful opioid dose reduction or discontinuation in adults with CNCP ...
Alessandra C. Marcelo +8 more
wiley +1 more source
Medicinal Cannabis Use in Sickle Cell Anemia [PDF]
, 2018 Approximately 100,000 Americans suffer from sickle cell anemia (SCA), a severe hereditary form of anemia in which red blood cells can mutate into a sickled shape causing severe pain crises that can lead to ED visits, hospitalization, and negatively ...
Axelrod, MD, JD, David +3 more
core +1 more source
Drug Testing and Analysis, EarlyView.This study investigates the effect of the reaction temperature (step 1) and reaction time (step 1 and 2) on the conversion efficiency and impurity profile of amphetamine synthesized via the Leuckart method. Conversion efficiency and impurity profile were assessed using gas chromatography–flame ionization detection (GC–FID) and GC–mass spectrometry (GC ...
Maartje C. M. Verhoeven +7 more
wiley +1 more source
Non-Cannabinoid Metabolites of Cannabis sativa L. with Therapeutic Potential
Plants, 2021 The cannabis plant (Cannabis sativa L.) produces an estimated 545 chemical compounds of different biogenetic classes. In addition to economic value, many of these phytochemicals have medicinal and physiological activity. The plant is most popularly known
Henry Lowe +4 more
doaj +1 more source